top of page

Investor Talk : Kurma x Plassereau IP

Tue, Nov 03

|

THE HIVE by Kadans Science Partner

The PSCC Investor Talk series brings together startups and innovative companies from the PSCC Connect community with a leading investment fund active in life sciences and oncology. Upon invitation only, for PSCC Connect Start-ups

Investor Talk : Kurma x Plassereau IP
Investor Talk : Kurma x Plassereau IP

Time & Location

Nov 03, 2026, 5:30 PM – 7:00 PM

THE HIVE by Kadans Science Partner, 125 Rue Edouard Vaillant, 94800 Villejuif, France

About the event

The PSCC Investor Talk series brings together startups and innovative companies from the PSCC Connect community with a leading investment fund active in life sciences and oncology.


Each edition offers a direct and informal exchange between entrepreneurs and investors: the invited fund presents its investment strategy, current priorities, and portfolio focus. The talk is followed by an open discussion and networking reception.


For this edition, we will welcome :

  • Rémi Droller, Partner, Kurma Partner

Since 2010, Rémi has been instrumental in the creation of a dozen biotechnology companies in Europe of which he was Chairman of the Board of Directors and Director thereafter. Rémi holds a Master’s degree in Molecular Biology (Paris VI) and a Master’s degree in Finance and Innovation Management (Masternova – AgroPariTech).


  • Denis Bourgarel, Partner, French & European Patent Attorney and Life Sciences Patent Practice Group Leader at Plasseraud IP. 

Denis assists numerous biotech companies and start-ups in their IP strategy and global management of their patent portfolio for maximizing the exclusivity of their development product. Denis also participated in numerous IP due diligences either from investor's side or for companies for fund raising, IPO or other deals. 



These sessions are exclusive to PSCC Connect members and represent a unique opportunity to engage with key financial stakeholders in the oncology innovation ecosyste

Google Maps were blocked due to your Analytics and functional cookie settings.

Share this event

bottom of page